PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 11098562

Left ventricular restoration by endoventricular circular patch plasty (EVCPP).

V Dor
View original source ↗Export metadata ↓

Abstract

The Endoventricular Circular Patch Plasty technique, developed to reorganize the left ventricular cavity after post-ischemic modification, is described as it has been used since 1984. Experience of more than 900 cases demonstrates the efficiency of the technique in terms of left ventricular shape, left ventricular performances and long-term clinical results. Particular attention is focused on very large asynergia with congestive heart failure.

Explore related subjects

Aortic ValveCardiac Surgical ProceduresCryotherapyEndocardiumHeart AneurysmHeart FailureHeart Valve Prosthesis ImplantationHeart VentriclesHemodynamicsHumansMitral ValveMyocardial InfarctionMyocardial IschemiaMyocardial RevascularizationNecrosisPericardiumPolytetrafluoroethylenePostoperative ComplicationsProstheses and ImplantsRecurrenceSuture TechniquesVentricular Dysfunction, LeftJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

V Dor. 2000. Left ventricular restoration by endoventricular circular patch plasty (EVCPP).. https://pubmed.ncbi.nlm.nih.gov/11098562/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

HMG CoA reductase inhibitor (statin) and aortic valve calcium.

There is no known pharmacological therapy for calcific aortic valvular sclerosis or stenosis. Because leaflet calcification occurs in areas of lipoprotein deposition, we hypothesised that 3-hydroxy-3-methylglutaryl-coenzyme A (HMG COA) reductase inhibitors (statins) might slow aortic valve calcium (AVC) accumulation. We retrospectively identified 65 patients who had undergone two electron-beam computed tomography scans at a mean (SD) interval of 2.5 (1.6) years. 28 (43%) patients were receiving statins. Patients who were treated with statins had a 62-63% lower median rate of AVC accumulation (p=0.006) and 44-49% fewer statin patients had definite AVC progression (p=0.043). These findings suggest that statins may decrease AVC accumulation.

Aortic Valve↗
PubMed2002

Aortic valve sclerosis as a marker of active atherosclerosis.

Aortic sclerosis is a calcific disease of the aortic valvular leaflets defined as focal leaflet thickening without significant obstruction to left ventricular outflow. Several clinical factors are associated with calcific aortic valve disease, including male sex, smoking, hypertension, age, hypercholesterolemia, and diabetes. Histologic and biochemical studies suggest similarities between the mechanisms involved in the development of aortic sclerosis and atherosclerosis, suggesting these two diseases may share common pathophysiologic mechanisms. In a recent prospective trial, the presence of aortic sclerosis was associated with an approximately 50% increase in cardiovascular mortality and myocardial infarction, even after correction for age, gender, known coronary artery disease, and clinical factors associated with a aortic sclerosis.

Aortic Valve↗